4.7 Letter

Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first- line treatment of metastatic colorectal cancer: Updated results from the BICC-C study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Meeting Abstract Oncology

A phase I trial of RX-0201 (AKT anti-sense) in patients with an advanced cancer

J. Marshall et al.

JOURNAL OF CLINICAL ONCOLOGY (2007)